ALIX(1-702)-mNeonGreen
(Plasmid
#191193)
-
PurposeTruncated form of ALIX that lacks C-terminal proline-rich domain; C-terminally tagged with mNeonGreen.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 191193 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5396
- Total vector size (bp) 8225
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameALIX (1-702)
-
Alt namePDCD6IP (1-702)
-
SpeciesH. sapiens (human), Synthetic
-
Insert Size (bp)2829
-
MutationDeletion of ALIX C-terminal PRD.
-
Entrez GenePDCD6IP (a.k.a. AIP1, ALIX, DRIP4, HP95, MCPH29)
- Promoter CMV
-
Tags
/ Fusion Proteins
- 6xHIS (N terminal on insert)
- mNeonGreen (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer CMV forward
- 3′ sequencing primer BGH reverse (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byALIX (1-702) cDNA was provided by Lalit Deshmukh (UCSD)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
ALIX(1-702)-mNeonGreen was a gift from Jin Zhang (Addgene plasmid # 191193 ; http://n2t.net/addgene:191193 ; RRID:Addgene_191193) -
For your References section:
Reversible phase separation of ESCRT protein ALIX through tyrosine phosphorylation. Elias RD, Zhu Y, Su Q, Ghirlando R, Zhang J, Deshmukh L. Sci Adv. 2023 Jul 14;9(28):eadg3913. doi: 10.1126/sciadv.adg3913. Epub 2023 Jul 14. 10.1126/sciadv.adg3913 PubMed 37450591